Dirk M. van der Steen

Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia

Dyantha I. van der Lee, Rogier M. Reijmers, Maria W. Honders et al. · Journal of Clinical Investigation · 2019 · 230 citations · Full text

Life Sciences, Immunology, Oncology +17

PRAME-Specific Allo-HLA–Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer

Avital L. Amir, Dirk M. van der Steen, Marleen M. van Loenen et al. · Clinical Cancer Research · 2011 · 120 citations

Life Sciences, Immunology, Oncology +17

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma

Gülçin Gezgin, Sietse J. Luk, Jinfeng Cao et al. · JAMA Ophthalmology · 2017 · 117 citations · Full text

Medicine, Immunology, Oncology +17

Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection

Maarten L. Zandvliet, J.H. Frederik Falkenburg, Ellis van Liempt et al. · Haematologica · 2010 · 70 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Allo-HLA–reactive T cells inducing graft-versus-host disease are single peptide specific

Avital L. Amir, Dirk M. van der Steen, Renate S. Hagedoorn et al. · Blood · 2011 · 64 citations · Full text

Life Sciences, Immunology, Pathology +14